Company / SG&A per Share
Kiniksa Pharmaceuticals International, plc SG&A per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$2.73
FY2025
5-year range
$0.65 / $2.73
FY2021-FY2025
Trend
+14.4%
vs FY2024
Sector context
#67 of 210
Health Care
What the data says
At $2.73, Kiniksa Pharmaceuticals International, plc's sg&a per share ranks #144 of 210 in the Health Care sector. SG&A per Share has increased for 4 consecutive years, from $0.65 in FY2021 to $2.73 in FY2025.
Based on SEC 10-K filings.
2.73 in FY2025 with a 5-year CAGR of +30.1%.
Increased from $1.89 to $2.73 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +19.9%
- 5-Year CAGR
- +30.1%
- 10-Year CAGR
- -
Sector benchmark
#144 of 210 in Health CareTop 68% of 210This company $2.73 Sector average $29.50
▼
-90.8% below sector average
Key checks
Key Insights
- Kiniksa Pharmaceuticals International, plc's sg&a per share has grown for 4 consecutive years.
- In FY2025, sg&a per share increased 14.4% year-over-year.
- Ranks #67 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2017.
Company context
Key Data Points
- Negative profit margin: -10.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.73 | +14.4% |
| FY2024 | $2.39 | +26.4% |
| FY2023 | $1.89 | +19.2% |
| FY2022 | $1.58 | +144.9% |
| FY2021 | $0.65 | -11.7% |
| FY2020 | $0.73 | +13.3% |
| FY2019 | $0.65 | -11.4% |
| FY2018 | $0.73 | -85.4% |
| FY2017 | $5.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026